Opaleye Management Inc. Quant / Systematic

CIK: 0001595855 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $242,132 (100.0% shares, 0.0% debt)

Holdings (42)

HROW HARROW HEALTH INC 16.7%
Value ($000) $40,360 Shares 3,343,817 Est. Cost $5.30 Unrealized +53.0%
OCUL OCULAR THERAPEUTIX INC 11.1%
Value ($000) $26,830 Shares 6,465,000 Est. Cost $5.00 Unrealized +0.8%
RYTM RHYTHM PHARMACEUTICALS INC 8.2%
Value ($000) $19,845 Shares 810,000 Est. Cost $12.73 Unrealized +46.1%
TELA TELA BIO INC 7.2%
Value ($000) $17,351 Shares 2,036,551 Est. Cost $9.45 Unrealized -12.3%
CRNX CRINETICS PHARMACEUTICALS INC 5.4%
Value ($000) $13,184 Shares 671,300 Est. Cost $21.12 Unrealized -3.4%
CYTK CYTOKINETICS INC 5.3%
Value ($000) $12,742 Shares 263,000 Est. Cost $18.45 Unrealized +160.9%
KROS KEROS THERAPEUTICS INC 5.0%
Value ($000) $12,087 Shares 321,300 Est. Cost $49.36 Unrealized -29.8%
TARA PROTARA THERAPEUTICS INC 3.3%
Value ($000) $7,993 Shares 2,708,067 Est. Cost $29.10 Unrealized -88.4%
CDXS CODEXIS INC 2.9%
Value ($000) $6,999 Shares 1,155,000 Est. Cost $3.62 Unrealized +121.9%
TRACON PHARMACEUTICALS INC 2.9%
Value ($000) $6,997 Shares 4,190,000 Est. Cost $4.80 Unrealized
CUTERA INC 2.8%
Value ($000) $6,735 Shares 147,700 Est. Cost $37.50 Unrealized
EWTX EDGEWISE THERAPEUTICS INC 2.6%
Value ($000) $6,248 Shares 635,000 Est. Cost $10.83 Unrealized -6.7%
MERSANA THERAPEUTICS INC 2.5%
Value ($000) $6,086 Shares 900,300 Est. Cost $4.19 Unrealized
LRMR LARIMAR THERAPEUTICS INC 2.2%
Value ($000) $5,318 Shares 1,661,784 Est. Cost $7.31 Unrealized -65.7%
ETON ETON PHARMACEUTICALS INC 2.2%
Value ($000) $5,294 Shares 2,521,000 Est. Cost $6.13 Unrealized -59.3%
INHIBRX INC 2.2%
Value ($000) $5,254 Shares 292,700 Est. Cost $11.35 Unrealized
MERUS N.V. 2.1%
Value ($000) $5,072 Shares 253,200 Est. Cost $28.57 Unrealized
PCVX VAXCYTE INC 1.9%
Value ($000) $4,560 Shares 190,000 Est. Cost $38.73 Unrealized -34.5%
XOMA XOMA CORP DEL 1.8%
Value ($000) $4,442 Shares 248,000 Est. Cost $10.28 Unrealized +100.5%
URGN UROGEN PHARMA LTD 1.4%
Value ($000) $3,307 Shares 397,500 Est. Cost $7.43 Unrealized +11.4%
LQDA LIQUIDIA CORPORATION 1.3%
Value ($000) $3,065 Shares 563,500 Est. Cost $5.49 Unrealized +2.3%
FDMT 4D MOLECULAR THERAPEUTICS INC 1.2%
Value ($000) $2,820 Shares 350,700 Est. Cost $20.97 Unrealized -56.8%
STXS STEREOTAXIS INC 1.2%
Value ($000) $2,802 Shares 1,556,800 Est. Cost $2.93 Unrealized -27.0%
FORTRESS BIOTECH INC 1.1%
Value ($000) $2,579 Shares 2,999,000 Est. Cost $2.69 Unrealized
PRQR PROQR THERAPEUTICS NV 1.0%
Value ($000) $2,318 Shares 3,115,000 Est. Cost $3.64 Unrealized -78.0%
GRAPHITE BIO INC 0.8%
Value ($000) $1,830 Shares 577,250 Est. Cost $3.88 Unrealized
THESEUS PHARMACEUTICALS INC 0.5%
Value ($000) $1,280 Shares 220,650 Est. Cost $5.76 Unrealized
IMPEL PHARMACEUTICALS INC 0.5%
Value ($000) $1,243 Shares 255,250 Est. Cost $7.39 Unrealized
ASTRIA THERAPEUTICS INC 0.5%
Value ($000) $1,207 Shares 133,500 Est. Cost $9.04 Unrealized
MODD MODULAR MEDICAL INC 0.5%
Value ($000) $1,135 Shares 275,422 Est. Cost $3.92 Unrealized +15.9%
ALLAKOS INC 0.4%
Value ($000) $939 Shares 153,500 Est. Cost $6.12 Unrealized
CHIMERIX INC 0.3%
Value ($000) $704 Shares 365,000 Est. Cost $4.26 Unrealized
DERM JOURNEY MEDICINE CORP 0.3%
Value ($000) $638 Shares 259,293 Est. Cost $4.19 Unrealized -18.8%
MORPHOSYS AG 0.3%
Value ($000) $609 Shares 121,015 Est. Cost $5.03 Unrealized
EDAP EDAP TMS SA 0.2%
Value ($000) $588 Shares 71,300 Est. Cost $8.25 Unrealized
NPCE NEUROPACE INC 0.2%
Value ($000) $436 Shares 116,324 Est. Cost $6.20 Unrealized -22.3%
LUMOS PHARMA INC 0.2%
Value ($000) $412 Shares 46,576 Est. Cost $8.32 Unrealized
NEOLEUKIN THERAPEUTICS INC 0.2%
Value ($000) $368 Shares 575,000 Est. Cost $5.58 Unrealized
OPTINOSE INC 0.1%
Value ($000) $333 Shares 90,970 Est. Cost $3.66 Unrealized
MGTX MEIRAGTX HLDGS PLC 0.0%
Value ($000) $84 Shares 10,000 Est. Cost $8.82 Unrealized 0.0%
IDYA IDEAYA BIOSCIENCES INC 0.0%
Value ($000) $22 Shares 1,500 Est. Cost $12.99 Unrealized 0.0%
BIOLINERX LTD 0.0%
Value ($000) $16 Shares 16,667 Est. Cost $1.74 Unrealized